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Abstract: Vaccines against classical swine fever have proven very effective in protecting pigs from
this deadly disease. However, little is known about how vaccination impacts the selective pressures
acting on the classical swine fever virus (CSFV). Here we use high-throughput sequencing of viral
genomes to investigate evolutionary changes in virus populations following the challenge of naïve
and vaccinated pigs with the highly virulent CSFV strain “Koslov”. The challenge inoculum contained
an ensemble of closely related viral sequences, with three major haplotypes being present, termed
A, B, and C. After the challenge, the viral haplotype A was preferentially located within the tonsils
of naïve animals but was highly prevalent in the sera of all vaccinated animals. We find that the
viral population structure in naïve pigs after infection is very similar to that in the original inoculum.
In contrast, the viral population in vaccinated pigs, which only underwent transient low-level viremia,
displayed several distinct changes including the emergence of 16 unique non-synonymous single
nucleotide polymorphisms (SNPs) that were not detectable in the challenge inoculum. Further
analysis showed a significant loss of heterogeneity and an increasing positive selection acting on the
virus populations in the vaccinated pigs. We conclude that vaccination imposes a strong selective
pressure on viruses that subsequently replicate within the vaccinated animal.
Keywords: vaccination; virus evolution; classical swine fever virus; CSFV; virulence; deep sequencing;
viral populations; haplotype selection
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1. Introduction
RNA viruses have some of the highest mutation rates known in nature [1]. This allows them
to adapt quickly to selective pressures such as host immune responses. Classical swine fever virus
(CSFV), an RNA virus belonging to the genus Pestivirus within the Flaviviridae family [2], also displays
this characteristic. CSFV is the causative agent of classical swine fever (CSF) and exists as multiple
genotypes with varying phenotypes ranging from high to low virulence [3,4]. Studies on CSFV have
revealed that highly virulent viruses have higher sequence diversity compared to viruses of lower
virulence [5]. Whether this high diversity is necessary for high virulence is not fully understood [6,7].
However, high diversity and quasispecies development have been linked to virulence and tissue
tropism in picornaviruses [8,9]. The ability of CSFV to adapt quickly during virus replication has been
observed in modified, live, attenuated vaccine-viruses in which key changes revert to their parental
state after a few passages in cell culture [10]. A study of CSFV adaptation in vivo of another live,
attenuated vaccine strain (GPE-) also found the reversion of key motifs after extensive passaging in
pigs resulting in a more virulent form [11]. Furthermore, evolution to higher virulence occurred within
animals infected with a mutant (and less virulent) form of the usually highly virulent CSFV strain
“Koslov” [7]. Adaptation under high selective pressure (such as during antiviral treatment, in the
presence of neutralizing antibodies or following vaccination) has the potential to lead to the selection
of adaptive escape variants. Examples of this process have been described in vivo and in vitro with
the hepatitis C virus (HCV) [12–15] and in vitro for CSFV [16].
Vaccination studies typically focus on the efficacy and safety of the CSF vaccine candidates [17].
However, vaccinated animals often show low-level and transient viral RNA loads after a subsequent
virus challenge [18–22]. This indicates that some replication of the challenge virus occurs under the
strong selective pressure imposed by the immune system. We have here undertaken a detailed analysis
of the virus subpopulations present during this transient period of viremia, in order to analyse the
evolutionary processes taking place. Further exploration of evolutionary events in vaccinated animals
should facilitate a better understanding of the adaptive potential of the challenge virus and thereby the
protective capabilities of vaccine candidates. Next-generation sequencing (NGS) technologies have
made it possible to study the evolution of virus populations in great detail. In particular, the use
of deep sequencing allows for the identification of low-frequency single nucleotide polymorphisms
(SNPs) in virus populations, something that has previously been possible only by end-point limiting
dilution or extensive cDNA cloning.
In this study, full-genome sequencing of the challenge virus was performed on samples obtained
from pigs that were first inoculated with one of two different live attenuated CSF vaccine candidates
and subsequently challenged with the highly virulent CSFV strain “Koslov”. Deep sequencing allowed
detailed analyses of the virus populations present within the challenge inoculum and within both
naïve and vaccinated animals post-challenge.
2. Materials and Methods
2.1. Vaccine and Challenge Virus
CSFV C-strain vaccine vR26 and the chimeric derivative vR26_E2gif [10], with vR26_E2gif having
the complete E2 sequence from border disease virus (BDV) strain “Gifhorn” [23], were used for
the vaccination of pigs. Blood from a pig infected with the highly virulent CSFV strain “Koslov”
(CSFV/1.1/dp/CSF0382/XXXX/Koslov) was used as the challenge inoculum [20].
2.2. Vaccination and Challenge Infection of Animals
A vaccination/challenge experiment including 21 pigs was performed to assess the vaccine
properties of vR26 and vR26_E2gif [10]. In brief, 2 groups of 6 pigs (p1-p6 and p10-p15; 6 weeks old),
in separate pens, were vaccinated intramuscularly with either vR26_E2gif (2 × 107.7 TCID50) or vR26
(2 × 106.9 TCID50). Each vaccine batch was prepared from the 12th passage in SFT-R cells [10]. Further,
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3 additional pigs in each group (p7–p9 and p16–p18) served as sentinel animals. A further 3 animals
(p19–p21), housed in a separate pen, were mock-vaccinated with cell culture medium and served as
the challenge control group (termed naïve). Four weeks later (post-infection day (PID) 0), all pigs,
except for the sentinels, were challenged, by the oronasal route, with the CSFV strain “Koslov” (2 × 106
TCID50). Clinical signs and rectal body temperature were monitored on a daily basis and scored as
previously described [24]. Blood samples and nasal swabs were examined for viral RNA load using
quantitative RT-PCR (RT-qPCR) assays and serum samples were tested for anti-CSFV E2 antibodies by
ELISA [7,18]. All experimental procedures, including euthanasia, animal care, and maintenance were
conducted in accordance with Danish and EU legislation (Consolidation Act 474 15/05/2014 and EU
Directive 2010/63/EU) and with the approval from the Danish Animal Experimentation Inspectorate
(license number 2008/561-1541).
2.3. RNA Extraction and NGS
RNA was extracted from selected samples using a modified Trizol/RNeasy protocol as previously
described [25]. Briefly, RNA was extracted from the challenge inoculum, blood, and serum samples
using Trizol LS (Invitrogen, Carlsbad, USA), the aqueous phase containing the RNA was applied to an
RNeasy spin column (Qiagen, Hilden, Germany) and RNA was eluted in nuclease-free H2O. For RNA
extraction from tonsils, the tissue was cut into small pieces with sterile scissors. A 100 mg of tissue was
added to Trizol LS (750 µL) and H2O (250 µL) in a 1.5 mL tube. One steel ball was placed in each tube
and processed in a Tissuelyser (Qiagen) at 25 Hz for 1 min. RNA from the resultant homogenate was
then extracted as above. The CSFV RNAs from the virus inoculum, blood, and tonsils, with similarly
high CSFV RNA levels, were amplified as cDNA by full-length RT-PCR as described [7], whereas the
RNA from pigs with low viral loads, where full-length amplification failed, was amplified as two
overlapping cDNA fragments (each approximately 6 kbp) using a modified protocol. This modified
protocol used an RT step primed by two specific primers (CSF-Kos-6240-RT 5′ TCT ATA GGG TGT TTC
TGC CC 3′ and 3′CSF-kos_rev-RT 5′ GGG CCG TTA GGA AAT TAC CTT AGT 3′ [26]. Subsequent
amplification of the cDNA was achieved within two separate PCRs to cover the entire genome (the
primers used were: 5′ end: CSF-Kos_Not1-T7-1-59 5′TCT ATA TGC GGC CGC TAA TAC GAC TCA
CTA TAG TAT ACG AGG TTA GTT CAT TCT CGT ATG CAT GAT TGG ACA AAT CAA AAT TTC
AAT TTG G 3′ [7] with CSF-Kos-6176-R 5′ CTG GTG TTG CGG TCA TGG CTA CTA C 3′) and (3′
end CSF-Kos-5981-F 5′GGG GAG ATG AAA GAA GGG GAC ATG 3′ with CSF-kos_12313aR 5′ GGG
CCG TTA GGA AAT TAC CTT AGT CCA ACT GT 3′ [26]). The two fragments were pooled in equal
amounts (2 × 250 ng) and sequenced (see below). RNA extracted from blood by MagnaPure extraction
(Roche, Basel, Switzerland), as used for the RT-qPCR, was also amplified with this modified protocol.
In order to get adequate amounts of these RT-PCR products from tissues (in this case tonsils) that
contain high levels of host RNA, a modified RNA extraction was applied. The aqueous phase from the
Trizol extraction containing the RNA was fractionated on an RNeasy column, five separate eluates
were analysed using full-length RT-PCRs. The strongest and clearest products corresponding to the
full-length CSFV cDNA were generated from fractions 3 to 5 (Table S1).
NGS was performed on both the RT-PCR products and on RNA using the Ion Plus fragment library
kit (Life Technologies, Carlsbad, USA) and sequenced by the Ion PGM platform (Life Technologies)
using the SPRIworks—Fragment Library System II (Beckman Coulter, Krefeld, Germany) for the FLX
platforms (Table S2).
2.4. Analysis of Sequence Data
FastQC [27] was applied for pre-trimming evaluation of the Fastq files containing the raw sequence
reads. Trimming and primer removal were performed using cut-adapt and prinseq-lite [28]. Fastq files
were error-corrected using RC454 [29] with the CSFV strain “Koslov” nucleotide sequence (GenBank
HM237795; [26]) as reference. The de novo assembly was performed using Newbler 2.6 (Roche software,
Basel, Switzerland). Each error-corrected Fastq file was aligned using the BWA-MEM [30] algorithm
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or Mosaik [31]. Subsequently, the libraries were post-processed with Samtools [32] and SNPs were
called using lofreq [33]. Downstream SNP effect analysis was performed with snpEff [34] with no
fraction cut-off set. SNP plots were made in R. dN/dS and piN/piS analyses were performed by taking
the filtered SNP calls and running them through SNPGenie [35] with a SNP cut-off set at 1%. Statistical
analysis was performed with Graphpad Prism using the T-test with Holm–Sidak correction for multiple
comparisons when appropriate.
3. Results
3.1. Vaccinated Pigs Are Protected against Challenge with CSFV but Display Transient, Low Levels of Viral
RNA in Blood
All pigs in the naïve (unvaccinated) group, that were challenged with the highly virulent CSFV
strain “Koslov”, developed a high fever shortly after challenge (Figure 1a) and were euthanized due
to severe clinical signs of CSF within 6 days (Figure 1b). High viral loads were observed in blood
and nasal swabs (Figure 1c,d). Pigs previously vaccinated with the CSFV C-strain vR26 and the
chimeric vR26_E2gif [10] all survived the viral inoculation that lead to 100% mortality in the naïve
pigs (Figure 1b). Transient fever was observed in the vaccinated animals after the challenge, with the
highest temperatures seen in the vR26_E2gif vaccinated pigs (Figure 1a). Low levels of viral RNA
were observed, between PID3 and PID10, in blood samples from the vR26_E2gif vaccinated pigs,
whereas vR26 vaccinated pigs showed lower viral RNA levels between PID3 and PID7 post-challenge
(Figure 1c). None of the vaccinated pigs had detectable levels of viral RNA in the nasal swab samples
collected post-challenge (Figure 1d).
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Figure 1. Naïve pigs (n = 3) or pigs vaccinated with vR26 (n = 6), or vR26_E2gif (n = 6) were challenged
with the highly virulent classical swine fever virus (CSFV) strain “Koslov”. The graphs show the (mean
± SEM values where appropriate) for: (a) body temperature, (b) pig survival (%), (c) viral RNA in
blood, measured by RT-qPCR, shown as 50-ct, and (d) viral RNA in nasal swabs measured by RT-qPCR.
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The vaccine virus was not detectable in blood at any time before challenge (Figure 1c,d).
Furthermore, all pigs vaccinated with vR26 seroconverted against the CSFV E2 within 21 days
of the vaccination, whereas pigs vaccinated with the chimeric vR26_E2gif (that expresses the BDV E2
protein) only seroconverted against CSFV E2 after the Koslov challenge (Figure S1). Transmission of
the CSFV vaccine or challenge virus to sentinel pigs was not observed; they all remained negative by
RT-qPCR throughout the experiment and did not seroconvert.
3.2. Deep Sequencing of Virus in the Challenge Inoculum Shows a Heterogeneous Population with a Consensus
Sequence Identical to the Koslov Reference
The virus inoculum used for the challenge infection was deep-sequenced from full-length
RT-PCR amplicons and directly from the RNA (Figure 2a,b). The sequencing of the amplicons
showed the consensus to be 100% identical to the reference sequence for the CSFV strain “Koslov”
(Genbank HM237795). However, variant calling showed that the underlying viral population is in
fact quite heterogeneous (Figure 2a) with 10 SNPs having frequencies of about 40%. One of these is a
non-synonymous change in the E2 protein, C2661T corresponding to the amino acid change S763L
(residue 74 in the E2 protein) that is situated on the surface of domain 1 in the antigenic region B/C,
whereas the other nine SNPs are all synonymous (C2134T, G3205A, T4150C, C4612G, T4750C, G5101A,
T9940C, A10669G, and G11374C). All other SNPs detected (149 in total) had frequencies between 1%
and 10% with the majority corresponding to synonymous mutations. Direct sequencing of viral RNA
from the inoculum confirmed these results by having a similar SNP profile (Figure 2b).
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Figure 2. Single nucleotide polymorphism (SNP) frequency plots of the challenge virus in the inoculum.
SNPs with a frequency above 20% are indicated for each sample type as follows: (a) Virus inoculum
(determined following RT-PCR), and (b) virus inoculum (determined directly from the RNA). The red,
green and blue colours of the bars represent non-synonymous, synonymous and untranslated region
(UTR) mutations, respectively.
3.3. Analysis of CSFV Sequences in Naïve and Vaccinated Animals Following Challenge with the Koslov Strain
To investigate evolutionary changes in the virus population after challenge, we generated sequence
data from both the naïve and vaccinated animals. From the naïve group, we sequenced virus extracted
from serum samples at PID3 and PID6, as well as from blood and tonsil samples obtained at PID6
(Figure 3). In the vaccinated group, viral loads after challenge were low but we obtained NGS data
determined following RT-PCR from serum samples obtained at PID5 from three vR26_E2gif vaccinated
pigs and from one pig vaccinated with the vR26 (Figure 4a–d). This NGS data represented exclusively
the challenge virus population since vaccine virus is not amplified by this RT-PCR. Figures 3 and 4
show the frequencies of all SNPs found in the viral populations from naïve and vaccinated animals,
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while Figure 5 shows the change in SNP frequencies between the inoculum and samples from naïve or
vaccinated animals.
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Figure 3. SNP frequency plots of the virus in the naïve pigs (p19, p20, and p21 respectively) following
virus challenge. SNPs present at a frequency above 20% are indicated on each plot in the following
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frequency plots for serum (PID6) were determined directly from RNA, whereas the others were
determined following RT-PCR. The red, green, and blue colours of the bars represent non-synonymous,
synonymous, and untranslated region (UTR) mutations, respectively.
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Table 1. SNPs in vaccinated animals compared to naïve animals.
Protein NucleotidePosition Inoculum (nt) Variant (nt)
Vaccinated
(serum) SNP
Frequency %
Vaccinated
(serum) SNP
Frequency ∆ %
Naïve
(serum) SNP
Frequency %
Naïve
(tonsils) SNP
Frequency %
SNP Effect Comments
Npro
425 A G 5.1 5.1 - - M18V *
547 A G 6.1 6.1 - 6.4 - *
658 C T 7.7 3.0 - 3.6 -
725 A G 5.1 5.1 - 1.7 I118V *
814 C T 3.1 0.6 1.3 1.5 -
C 1057 T C 8.9 5.9 2.5 3.8 -
Erns 1774 A G 4.6 4.6 - 1.3 - *
E1
2024 T C 13.8 7.2 1.52 9.4 F551L
2395 C T 6.6 2.6 0.7 5.8 -
E2
2617 T C 9.5 5.8 2.8 5.5 -
2650 T C 3.9 3.9 - 1.5 - *
2661 C T 89.3 47.8 18.6 58.9 S763L
2935 G A 6.7 4.2 1.65 3.1 M854I
3205 G A 87.7 43.6 21.7 60.1 -
3244 A G 6.5 3.5 0.6 6.4 -
3310 G A 7.4 7.4 - - - *
p7 3765 A G 9.1 9.1 - 5.6 K1131R *
NS2-3
3782 G A 8.1 5.1 0.7 5.1 G1137S
3853 G A 6.8 3.8 1.1 3.2 -
3907 G A 2.9 2.9 - - - *
3931 T C 1.8 1.9 - 2.0 - *
3965 G A 1.5 1.5 - - V1198M *
4168 A G 3.3 3.3 - 2.4 - *
4612 C G 87.7 44.2 23.0 59.0 -
4729 A G 15.2 7.2 2.7 9.2 -
4750 T C 88.3 46.2 22.1 59.6 -
4760 G A 6.2 6.2 - 3.6 V1463I *
4828 T C 6.8 6.8 1.45 4.7 -
5248 A G 6.0 2.2 3.0 3.4 -
5389 C T 9.2 5.7 0.7 3.7 -
5416 T C 15.4 9.5 1.9 9.3 -
6028 G A 1.6 1.6 - - - *
7006 G A 5.7 4.0 0.6 2.9 -
7021 T C 5.1 1.9 0.6 5.7 -
7099 A G 16.2 9.0 3.3 9.7 -
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Table 1. Cont.
Protein NucleotidePosition Inoculum (nt) Variant (nt)
Vaccinated
(serum) SNP
Frequency %
Vaccinated
(serum) SNP
Frequency ∆ %
Naïve
(serum) SNP
Frequency %
Naïve
(tonsils) SNP
Frequency %
SNP Effect Comments
NS4A
7304 T C 6.9 3.4 0.7 1.4 -
7318 A T 1.8 0.1 0.6 2.2 -
NS4B
7696 T C 7.2 4.5 2.3 4.0 -
7888 T C 5.6 5.6 1 2.9 -
8341 C T 9.5 5.9 1.4 5.0 -
NS5A
8500 C T 6.0 4.2 0.6 3.4 -
8878 G A 9.7 5.8 1.2 3.7 -
9241 A T 8.3 4.7 1.9 3.4 -
9396 A G 7.8 2.5 9.2 9.9 K3008R
9871 G A 5.8 5.9 1.4 3.6 -
9901 T C 1.6 1.6 - - - *
NS5B
9940 T C 85.7 43.9 17.6 59.2 -
10259 T C 4.8 4.8 - - - *
10402 C T 6.9 4.3 1.3 3.1 -
10669 A G 85.3 42.6 18.6 57.7 -
11242 T C 5.7 5.7 - - - *
11452 C T 5.4 2.3 - 6.1 -
11849 C T 7.4 5.0 2.3 3.5 -
11872 A G 6.5 3.5 - 4.0 -
3′ UTR 12083 C T 6.3 3.3 - 1.4 -
SNP frequencies are depicted as the average within each group. ∆% is the average SNP frequency compared to the inoculum frequency. * SNPs in vaccinated animals only and not in naïve
animals nor in virus inoculum. Grey shading represents SNPs present in haplotype A.
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Focusing on the more frequent SNPs, we found that the same 10 high-frequency SNPs that were
present in the inoculum were also present at high frequency in serum and blood from naïve animals.
In vaccinated animals, however, only 6 of these 10 SNPs, which included the non-synonymous mutation
C2661T, were present at high frequency (Figure 5b; Table 1). Closer analysis of the changes in SNP
frequencies between inoculum, and naïve or vaccinated animals, showed that, in naïve animals, 4 of
the 10 high-frequency SNPs increased in frequency, while the remaining six had decreased. The pattern
in vaccinated animals was exactly the opposite; in these animals the set of four SNPs had gone down
in frequency, essentially disappearing from the population, while the frequency of the remaining six
SNPs had gone up. Interestingly, tonsil samples from naïve animals showed the same pattern of SNPs
as the vaccinated animals (i.e., the same six SNPs increased in frequency).
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(b) Serum (PID5) from vaccinated pigs. (c) Blood (PID6) from naïve pigs. (d) Tonsils (PID6) from
naïve pigs. The red, green, and blue colours of the bars represent non-synonymous, synonymous,
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These results strongly suggested that at least two major haplotypes were present in the original
challenge inoculum. One of these (termed “haplotype A”) contains six SNPs compared to the
Koslov consensus reference (C2661T, G3205A, C4612G, T4750C, T9940C, and A10669G) of which the
C2661T change resulting in the S763L substitution is the only non-synonymous mutation. The second
(“haplotype B”) contains four synonymous SNPs compared to the reference (C2134T, T4150C, G5101A,
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and G11374C). Since the SNP frequencies of haplotype A and B do not add up to 100%, and since we
observed no other major SNPs compared to the Koslov reference, a third haplotype (“C”), identical to
the reference consensus sequence, can be inferred to make up the remainder of the virus population.
Figure 6 and Figure S2 summarise the distribution of these three haplotypes in the different groups
of animals and sample types. It can be seen that the haplotype composition in the inoculum is
about 40% A, 40% B, and 20% C. After challenge with this inoculum, in the vaccinated animals,
haplotype C (the Koslov consensus) essentially disappeared, while haplotype A, which includes the
non-synonymous SNP, became the dominant one. Indeed, in two of the four investigated animals,
haplotype B disappeared almost completely, while in the other two it decreased to 10%–20% of the
total. In the naïve animals, we found that the haplotype-distribution was different in different types
of samples, suggesting that the haplotypes may be associated with cell- or tissue-tropism. Thus,
tonsil samples from naïve animals were found to be similar to serum samples from vaccinated animals
in that haplotype A dominated, whereas serum samples displayed the opposite pattern, with a decrease
in the level of haplotype A and an increased proportion of B. Whole-blood was found to be similar to
the original inoculum.
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Figure 6. Haplotype distribution in virus populations of all samples across the complete ORF. Stacked
bar diagram showing the percentage distribution of haplotype A (C2661T (aa S763L), G3205A, C4612G,
T4750C, T9940C, and A10669G), B (C2134T, T4150C, G5101A, and G11374C), and C (Koslov consensus),
respectively. Haplotype distribution was calculated for each sample as the average of all SNPs
constituting the haplotype A or B and summed. The remaining percentage, subtracted from 100%,
was inferred to constitute haplotype C.
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The haplotypes described above were inferred based on frequencies (and changes of frequencies) of
individual SNPs obtained from short sequencing reads. This type of data contains limited information
about the linkage of genetic variants. Thus, in order to more directly investigate which haplotypes
were present, we cloned a large cDNA fragment covering the first half of the genome, derived from a
tonsil sample from one of the naïve pigs (p19), that spanned 6 out of the 10 high-frequency SNPs (at nt
2661, 3205, 4150, 4612, 4750, and 5101). By sequencing 15 separate clones, it was possible to see directly
which SNPs were linked to individual virus genomes (Table 2). The sequencing results confirmed
the presence of the two major inferred haplotypes A (C2661T, G3205A, C4612G, and T4750C) and B
(T4150C and G5101A) in 47% and 27% of the clones, respectively (Table 2). Furthermore, the inferred
haplotype C, without any of the six SNPs, was indeed found to be present in the rest of the clones
(Table 2).
Table 2. Identification of virus haplotypes.
cDNA * C2661T G3205A T4150C C4612G T4750C G5101A Haplotype
(S763L)
P19_1 + + - + + - A
P19_2 + + - + + - A
P19_3 + + - + + - A
P19_4 - - + - - + B
P19_5 + + - + + - A
P19_6 + + - + + - A
P19_7 - - + - - + B
P19_8 - - + - - + B
P19_9 - - - - - - C
P19_10 - - + - - + B
P19_11 - - - - - - C
P19_12 - - - - - - C
P19_13 - - - T ** - - C
P19_14 + + - + + - A
P19_15 + + - + + - A
* Individual cDNA clone derived from p19 tonsil. ** C4612T. Each (-) indicates that the variant was not detected in
the cDNA and (+) indicates that the variant was detected.
3.4. Loss of CSFV Population Heterogeneity and Targeted Positive Selection was Observed in the
Vaccinated Pigs
Population heterogeneity was quantified by calculating “nucleotide diversity”, i.e., the average
pairwise differences between sequences. The samples collected from the naïve pigs post-challenge all
showed increased virus diversity compared to the inoculum (Figure 7a). Vaccinated pigs, however,
were found to harbour viral populations that were much less heterogeneous than those in the naïve
animals, indicating differences in selective pressure in the two groups of animals.
Further analysis of positive selection in the individual samples was performed by estimating
the dN/dS and piN/piS ratios (where N and S indicate non-synonymous and synonymous changes
respectively). In general, dN/dS ORF ratios were well below 1 for all groups indicating that averaged
over all codons the viral proteins are under negative selection. In vaccinated animals, and in the tonsil
samples from naïve pigs, dN/dS was increased (but still well below 1), compared to the inoculum
(Figure 7b). This can be caused by relaxed negative selection, or the presence of some codons being
under positive selection (e.g., due to selective pressure to escape from the immune response). We also
observed differences in the viral sequences encoding the Npro, Erns, E1, and p7 proteins between the
vaccinated pigs and the naïve pigs (Figure 7c). When comparing the different sample types within the
naïve animals, we found an increase in the dN/dS ratio for the E2 and p7 protein-coding sequences in
the tonsils.
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To further investigate regions of the genome under positive selection, a sliding window analysis
was performed (Figure 7d) with the non-synonymous change C2661T producing the highest piN/piS
ratio in all groups.
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Figure 7. Population diversity derived by selection analysis of deep sequencing data. Panel (a)
shows the pair-wise genetic distance plotted for each individual sample type across the complete ORF.
Means ± SEM are shown for biological replicates (n = 3 and n = 4) for the naïve and vaccinated groups,
respectively, and technical replicates for the inoculum (n = 2). The T-test was applied to determine
significance differences between the vaccinated group compared to blood, tonsils, and serum (PID3
and PID6) of the samples from naïve pigs (p = 0.0242*, p = 0.1649, p = 0.070*, p = 0.0304*), respectively,
and to the challenge inoculum (p = 0.7598) with * indicating significant values. Panel (b) depicts
the dN/dS ratio plotted for each individual sample type for the total ORF. The T-test was applied,
as above, to determine significant differences between the vaccinated group compared to blood, tonsils,
and serum (PID3 and PID6) of the naïve samples (p = 0.0193*, p = 0.1165, p = 0.0033*, p = 0.0045*),
respectively, and to the inoculum (p = 0.0172*). Panel (c) shows the dN/dS ratios plotted for each
individual protein-coding sequence from the inoculum, vaccinated, and naïve groups. Panel (d) shows
the piN/piS ratios plotted as lines representing a 150 nt sliding window with the x-axis representing the
position in the genome.
This analysis revealed distinct sites in the virus samples from the vaccinated pigs in the Npro, E1,
and p7 to NS2 junction coding sequences compared to the naïve pigs pointing to positive selection
acting on these parts of the genome. One site displaying a particularly high piN/piS ratio was observed
within the Npro coding region; this is due to the non-synonymous SNP A425G (resulting in the M18V
substitution in the N-terminus of the protein). In the Erns coding region, there were non-synonymous
changes including several low-frequency SNPs that, in combination, and together with the low number
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of synonymous SNPs, resulted in the observed peak in the piN/piS ratio. Among the coding changes,
the SNP T2024C (F551L) gave rise to the elevated piN/piS ratio within the E1 coding region; this change
was detected in the vaccinated pigs but was also found in the inoculum but at a lower frequency.
The prominent peak in the piN/piS ratio located in the p7 protein-coding sequence is due to the
non-synonymous SNP A3765G (K1131R); this was not found in the inoculum while the nearby G3782A
(G1137S) change within the coding region for the NS2 protein could be detected in the inoculum.
4. Discussion
The chimeric pestivirus, vR26_E2gif, represents a C-strain based marker vaccine candidate against
CSF [10]. A vaccination/challenge experiment was performed to assess the vaccine properties of this
chimeric vaccine in comparison to the parental C-strain vaccine vR26. Our results demonstrated that
vR26_E2gif could efficiently protect pigs against disease with only transient fever being observed in
some vaccinated animals after challenge with the highly virulent CSFV Koslov. Notably, no transmission
was observed between the challenged animals and the sentinels. In addition, vaccination using the
vR26_E2gif could be efficiently discriminated from the use of the C-strain vaccine vR26 and wild-type
CSFV using the CSFV E2-specific antibody ELISA. This is an important feature of this marker vaccine
prototype. However, low levels of the challenge virus were observed in blood samples from the
vR26_E2gif vaccinated pigs between PID3 and PID10. Furthermore, the challenge virus was also
detected in pigs previously vaccinated with vR26, but to a lower extent. Therefore, we decided to
investigate the nature of the challenge virus present in the animals under the selective pressure imposed
by vaccination. Interference from the vaccine virus in the sequence data could be ruled out since no
vaccine virus was detected at any time after vaccination and the RT-PCR approach specifically targeted
the challenge virus population. Detailed SNP and dN/dS analysis allowed us to discover patterns of
change within the Koslov virus in the vaccinated animals that were not seen in the naïve animals.
In addition, we detected several amino acid residues under positive selection in the vaccinated animals
and an apparent haplotype tropism selection in the naïve animals.
Thus, the main focus of this study was the analysis of the molecular evolution of the virus
populations within infected pigs based on deep sequencing data. Deep sequencing of the inoculum
and samples from naïve and vaccinated animals showed that in all cases the viral populations were
heterogeneous, consisting of a cloud of related viral sequences with many low-frequency SNPs as well
as a few high-frequency variants. Closer analysis of changes in these SNP frequencies allowed us to
infer that the viral populations consisted of three main haplotypes (A, B, and C) that were closely
related. The first of these, haplotype A, had six SNPs compared to the Koslov reference sequence and
included a non-synonymous change at nt position 2661 (C2661T, corresponding to the amino acid
substitution S763L). The second one, haplotype B, contained four SNPs—all synonymous—compared to
the reference. The last one, haplotype C, was identical to the reference. The nature of these haplotypes
was confirmed by sequencing cloned fragments from a tonsil sample that covered 6 of the 10 SNPs in
single molecules.
Analysis of the composition of haplotypes in different samples from naïve and vaccinated animals
after viral challenge showed that haplotype A, which contains the non-synonymous change C2661T
(S763L) in the coding region for the E2 protein was selected for in the vaccinated pigs and also in the
tonsils of the naïve pigs. This suggests that haplotype A replicates more efficiently in the tonsils and
that this haplotype may be partially resistant to the immune response induced by vaccination, resulting
in its near fixation as observed in serum from vaccinated pigs. The virus in the blood from infected
naïve animals had a haplotype composition that was very similar to that found in the original challenge
inoculum, while virus in the serum from these same animals showed an increase in haplotype B relative
to A (i.e., the opposite pattern from that seen in vaccinated animals and in tonsils). The observation that
the haplotype composition of the virus in whole blood of naïve animals is the same as that in the virus
inoculum suggests that diversity is being actively maintained as has previously been observed for other
highly virulent CSFV populations [5]. Heterogeneity, in itself, is not necessary for high virulence as
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can be seen from the fact that virus rescued from a cDNA clone had similar virulence as the wild-type
inoculum [7]. It does, however, seem that tissue tropism and immune escape play a role in determining
haplotype composition and population heterogeneity as seen for other viruses [8,36]. Indeed, our data
suggest that haplotypes A and B, respectively, replicate most efficiently in two different tissues and
this could be why both are maintained in the naïve pigs.
The maintenance of the three haplotypes in the naïve pigs can be described as three peaks
within the fitness landscape around which there is a cloud of related suboptimal viruses. Most of the
low-frequency SNPs are removed by selection constantly, while the three main haplotypes may be
maintained by each having its own tissue in which it replicates well. However, vaccination shifts the
fitness landscape towards a higher fitness for haplotype A [37,38].
It seems relevant that amino acid residue 763, which is altered by one of the SNPs in haplotype A,
is situated within a putative epitope on the E2 surface protein of the virus [39]. Using the known 3D
structure of the E2 protein from bovine viral diarrhoea virus [40] as a model for the Koslov E2 protein,
we found that residue S763 (amino acid 74 in the E2 protein) is situated on the surface of domain 1
in the antigenic region B/C, suggesting a role in cell entry and immunogenicity. This region has also
been proposed to be involved in membrane fusion inside the endosomes that is facilitated by E1 at
low pH [40,41]. Both the CSFV C-strain and BDV Gifhorn have E2 proteins that contain leucine (L)
at position 763, while Koslov contains serine (S) at this site. It has previously been observed that the
adjacent amino acid, at position 764, could change from the L present in Koslov to the P [7] also found in
both the C-strain and Gifhorn. This indicates that the combination of these two positions is important
and this could explain why the vaccine constructs containing E2 Gifhorn as well as the E2 C-strain each
created an immune pressure to select for haplotype A of the Koslov challenge virus. However, further
studies using reverse genetics and in vitro and in vivo characterization of this epitope are needed to
completely understand these phenomena.
Virus from the serum of vaccinated pigs was found to have a higher dN/dS ratio than virus
in naïve pigs. This is consistent with an increased positive selective pressure being exerted by the
immune system in the vaccinated pigs driving adaptation, which leads to a slightly higher average
ratio although most codons are still under purifying selection (dN/dS < 1). We also found that viral
populations in vaccinated pigs were less diverse than those in naïve pigs; this again is probably
an effect of the pressure from the immune system. Sliding window analysis revealed that certain
residues within the Core, Erns, and p7 proteins were under positive selection especially within the p7
region. In addition, this analysis pointed towards the increase in dN/dS being the result of individual,
positively selected codons that emerged in response to the pressure from the prior vaccination. The
role of these residues could be interesting for future investigations of immune escape mechanisms. In
addition, within the naïve animals, virus present within tonsils displayed significantly higher levels of
positive selection for amino acid residues within the E2 and p7 proteins compared to the virus present
in blood and serum from the same animals.
We suggest that these analyses can benefit future virus vaccine studies by allowing identification
of adaptive mutations and sites important for potential immune escape of the challenge virus.
The knowledge gathered here may thus be useful for the production of improved live attenuated
vaccines and lead to an enhanced understanding of the adaptive potential of a virus.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/11/10/932/s1,
Figure S1: CSFV E2 specific antibodies detected by ELISA in naïve pigs or vaccinated pigs, Figure S2: Haplotype
distribution in virus populations of pooled samples analysed across the complete ORF, Table S1: RNA extraction
and RT-PCR amplification from tonsils, Table S2: Samples sequenced, NGS platform, and data analysis.
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